Oxford Immunotec Reports Second Quarter 2016 Financial Results
Second quarter revenue of $19.2 million, increased 34% compared to prior year period Raising revenue guidance for the full year from $79.5-$82.5 million to $82.5-$84.5 million Completed acquisition of Imugen, Inc. on July 1, 2016 for $22.2 million in all …